All lobbying filings
Miller Strategies, LLC
Miller Strategies, LLC filed a Q3 report for Amgen, Inc. on October 20, 2026, reporting $60,000 in lobbying income.
Lobbying for Amgen, Inc. · biopharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbying activity
3
Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars
Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Issues related to visas
Bills named in this filing
1